Wellell Inc. logo

Wellell Inc. (4106)

Market Closed
15 Jun, 05:30
TWSE TWSE
NT$
23. 20
-0.1
-0.4292%
NT$
2.17B Market Cap
19.23 P/E Ratio
- Div Yield
71,362 Volume
0 Eps
NT$ 23.3
Previous Close
Add Transaction
Day Range
23.15 23.6
Year Range
20.95 24.7
Want to track 4106 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

4106 closed today lower at NT$23.2, a decrease of -0.4292% from yesterday's close, completing a monthly decrease of -5.8824% or -NT$1.45. Over the past 12 months, 4106 stock gained 4.9774%.
4106 pays dividends to its shareholders, with the most recent payment made on Aug 26, 2025. The next estimated payment will be in In 2 months on Aug 26, 2026 for a total of NT$0.8.
The last earnings report, released on Mar 10, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Wellell Inc. has completed 9 stock splits, with the recent split occurring on Jul 26, 2011.
The company's stock is traded on one exchange.

4106 Chart

People also search for

Ch Biotech R&D Co. Ltd.
NT$ 90.5
+0.8919%
United Orthopedic Corporation
NT$ 89.8
-0.333%
Adimmune Corp
NT$ 17.7
+0.2833%
TaiGen Biopharmaceuticals Holdings Limited
NT$ 8.85
+0.1131%
Huxen Corp
NT$ 44.35
+0.681%

Wellell Inc. (4106) FAQ

What is the stock price today?

The current price is NT$23.20.

On which exchange is it traded?

Wellell Inc. is listed on TWSE.

What is its stock symbol?

The ticker symbol is 4106.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 2.17B.

Has Wellell Inc. ever had a stock split?

Wellell Inc. had 9 splits and the recent split was on Jul 26, 2011.

Wellell Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. Yong-Chuan Li CEO
TWSE Exchange
TW0004106000 ISIN
TW Country
- Employees
1 Aug 2023 Last Dividend
26 Jul 2011 Last Split
- IPO Date

Overview

Wellell Inc. is a globally recognized provider of medical solutions, specializing in products designed to support healthcare professionals in the management of patient care. Founded in 1990, the company is headquartered in New Taipei City, Taiwan. Wellell Inc. is dedicated to innovating and delivering medical devices and systems that meet the wide-ranging needs of patients and caregivers, focusing on wound management and respiratory therapy products among other medical equipment offerings. Through its commitment to quality and patient care, Wellell Inc. has established itself as a key player in the medical supply industry, striving to improve patient outcomes and healthcare experiences worldwide.

Products and Services

Wellell Inc. provides a comprehensive range of products aimed at improving the quality of care in various medical scenarios, primarily focusing on wound management and respiratory therapy. Each product is designed with patient care and comfort in mind, ensuring healthcare professionals have access to high-quality solutions.

  • Serene Air and Serene Elite: Alternating pressure redistribution systems for patients with high to very high risk for pressure ulcers. These systems are designed to minimize pressure points and enhance air circulation to support the healing and prevention of ulcers.
  • ACS Turn: A low air lateral turning mattress that helps in reducing the risk of pressure injuries through automatic turning, improving patient mobility and comfort.
  • Pro-care Optima: An alternating pressure redistribution system for patients with high to very high risk of pressure injuries, optimizing pressure distribution to prevent the formation of pressure ulcers.
  • Pro-care Turn: A bilateral turning air mattress catering to patients with medium to high risk of pressure injuries, facilitating regular movement and pressure alleviation.
  • Domus Auto, Domus 4, and Verso: Designed for patients with medium to high risk of pressure injury, these systems offer varying levels of support and pressure redistribution tailored to patient needs.
  • Domus 3: Targets patients with medium risk of pressure injury, providing a balanced support system for preventative care.
  • Domus 2s: Suited for patients with low to medium risk of pressure injury, this system provides basic pressure management and comfort.
  • Domus 1: A preventive mattress for patients in low risk of pressure injury, designed to offer foundational support and comfort.
  • Sedens 500 and Sedens 400: Seat cushions that provide pressure relief and support for patients confined to chairs for prolonged periods, helping prevent pressure ulcers.
  • Flexi-Air: A non-powered hybrid mattress that combines foam and air cells to deliver comfort and pressure redistribution without the need for power.
  • Respiratory Therapy Products: Including nasal masks, full face masks, nasal pillows mask, portable suction unit, and compressor nebulizers, as well as devices for positive airway pressure (iCH Auto and XT Auto) and continuous positive airway pressure (XT Prime, XT Sense, and XT Fit). The XT Heated Humidifier complements these systems by offering humidification to enhance patient comfort and therapy efficacy.

Contact Information

Address: No. 9, Min Sheng Street, New Taipei City, Taiwan, 23679
Phone: 886 2 2268 5568